SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063341
Filing Date
2023-11-14
Accepted
2023-11-14 06:50:42
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvl-20230930.htm   iXBRL 10-Q 2641062
2 EX-31.1 nuvl-ex31_1.htm EX-31.1 18658
3 EX-31.2 nuvl-ex31_2.htm EX-31.2 18648
4 EX-32.1 nuvl-ex32_1.htm EX-32.1 11431
5 EX-32.2 nuvl-ex32_2.htm EX-32.2 9745
  Complete submission text file 0000950170-23-063341.txt   6747934

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nuvl-20230930_cal.xml EX-101.CAL 24853
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvl-20230930_lab.xml EX-101.LAB 272048
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvl-20230930.xsd EX-101.SCH 29260
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvl-20230930_pre.xml EX-101.PRE 214134
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nuvl-20230930_def.xml EX-101.DEF 167432
46 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20230930_htm.xml XML 946936
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 231401487
SIC: 2834 Pharmaceutical Preparations